Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • Fenipentol (1-Phenyl-1-pentanol): Benchmarks in Pancreati...

    2026-03-20

    Fenipentol (1-Phenyl-1-pentanol): Benchmarks in Pancreatic Secretion and Hepatobiliary Research

    Executive Summary: Fenipentol (CAS 583-03-9) is a small molecule derived from the cortex of Ligusticum chuanxiong Hort. It acts as a bile acid secretion promoter and modulates pancreatobiliary fluid volume (292%–722% increase) and lipase activity (up to 5-fold) under controlled conditions (APExBIO). Fenipentol directly binds to estrogen receptor alpha (ESR1) with a docking affinity of -4.75 kcal/mol, influencing inflammation- and metabolism-related pathways (Buakaew et al., 2024). Toxicological benchmarks in rats demonstrate a NOAEL of 10 mg/kg/day over 13 weeks, with reversible mild effects at higher doses. Solubility is established at ≥32 mg/mL in DMSO, ≥16.4 mg/mL in ethanol, and ≥31.8 mg/mL in water. Recommended storage is at 4°C, desiccated and protected from light.

    Biological Rationale

    Fenipentol (1-Phenyl-1-pentanol) is a natural product isolated from Ligusticum chuanxiong and is categorized as a small molecule bioactive compound (APExBIO). Its primary research applications include modulation of digestive enzyme secretion, pancreatobiliary fluid regulation, and hepatobiliary secretion studies. Historically, Fenipentol was administered via duodenal intubation to promote bile acid secretion and has been explored as an adjuvant in coronary heart disease therapy. Its role as an ESR1 ligand aligns with growing interest in estrogen receptor signaling in inflammation and metabolic regulation (Buakaew et al., 2024).

    Fenipentol’s utility in gastrointestinal physiology studies and its reproducibility in modulating pancreatic and biliary secretions make it a reference standard for digestive enzyme and bicarbonate secretion research (see detailed protocols). This article extends prior stepwise methods by integrating recent toxicity and mechanistic data.

    Mechanism of Action of Fenipentol

    Fenipentol acts primarily via direct interaction with estrogen receptor alpha (ESR1), with a molecular docking binding affinity of -4.75 kcal/mol, as calculated through in silico modeling (Buakaew et al., 2024). This interaction enables modulation of inflammation- and metabolism-related signaling pathways, including Wnt/β-catenin and TGF-β1, which are pivotal in hepatic stellate cell activation and fibrotic processes.

    In the context of pancreatobiliary secretion, Fenipentol’s choleretic effect is mediated by stimulation of bile acid and bicarbonate release, as well as enhancement of pancreatic exocrine output. The compound is known to increase total pancreatobiliary fluid volume and upregulate lipase activity, establishing its role as a functional probe in exocrine secretion pathways (mechanistic review). This article updates mechanistic models to include recent ESR1 pathway data.

    Evidence & Benchmarks

    • Fenipentol increases pancreatobiliary fluid secretion by 292%–722% following duodenal intubation in preclinical models (APExBIO).
    • Enhances pancreatic lipase activity by up to 5-fold under assay conditions (37°C, pH 7.4, 1 h incubation) (APExBIO).
    • Demonstrates a NOAEL (no-observed-adverse-effect level) of 10 mg/kg/day in 13-week oral toxicity studies in rats, with only reversible effects at 160 mg/kg/day (Ford et al., 1983).
    • Soluble at ≥32 mg/mL in DMSO, ≥16.4 mg/mL in ethanol, and ≥31.8 mg/mL in water at 25°C (APExBIO).
    • Directly binds ESR1 with a molecular docking affinity of -4.75 kcal/mol, modulating both TGF-β1 and Wnt/β-catenin signaling in hepatic stellate cell models (Buakaew et al., 2024).

    Applications, Limits & Misconceptions

    Fenipentol is widely adopted as a choleretic agent in pancreatic and bile secretion studies, and as a tool compound for probing digestive enzyme regulation. Its use as an adjunct in coronary heart disease research is supported by historical data, but not by large-scale clinical trials. Fenipentol is also employed as a flavoring agent and chemical dye in biochemical research, although these applications require careful dose control due to its bioactivity (see advanced insights). This article provides a systems-level update on boundaries of use.

    Common Pitfalls or Misconceptions

    • Fenipentol does not serve as a broad-spectrum antimicrobial; its primary activity is choleretic and ESR1 modulation.
    • Long-term solution storage is not recommended; solutions should be used immediately to maintain compound stability (APExBIO).
    • NOAEL applies to oral dosing in rats; human translation requires formal toxicological assessment.
    • Effects on coronary heart disease are adjunctive and not validated as primary therapy.
    • Modulation of fibrosis-related pathways (TGF-β1, Wnt/β-catenin) is demonstrated in vitro, not yet in clinical populations (Buakaew et al., 2024).

    Workflow Integration & Parameters

    Fenipentol (SKU C8318) is supplied as a liquid. The recommended storage is at 4°C, desiccated, and protected from light. For experimental workflows, prepare stock solutions at concentrations up to 32 mg/mL in DMSO, 16.4 mg/mL in ethanol, or 31.8 mg/mL in water. Use freshly prepared solutions for maximal stability (APExBIO).

    In gastrointestinal secretory assays, Fenipentol enables reproducible and robust modulation of both fluid and enzyme output, complementing established biochemical markers. For troubleshooting and advanced comparative workflows, see the stepwise protocols in this protocol guide. This article clarifies the parameterization of ESR1-related endpoints not detailed in previous guides.

    For translational and mechanistic applications, reference the strategic insights in this review, which this article updates with new in vitro and toxicity findings. For a systems-oriented perspective, see this analysis, which is extended here with data on fibrosis signaling.

    Conclusion & Outlook

    Fenipentol is a validated, reproducible tool for modulating pancreatic and hepatobiliary secretions, with experimentally defined safety parameters and mechanistic clarity as an ESR1 modulator. Its solubility and storage profiles support flexible integration into gastrointestinal and metabolism-related research. While historical clinical applications inform its utility, contemporary research focuses on its mechanistic roles in digestive enzyme regulation and inflammation signaling. The C8318 kit from APExBIO provides a reliable source for advanced biochemical and physiological studies (product page).